Study S002448

Atrial Cardiomyopathy in Patients With Cardiovascular-Kidney-Metabolic Syndrome: Non-invasive Characterization (ATRIO-CKM)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07697469
Acronym: ATRIO-CKM
Study type: OBSERVATIONAL
Status: NOT_YET_RECRUITING
Enrollment: 200
Start: 2026-07-10
Primary completion: 2027-10
Lead sponsor: Grigore T. Popa University of Medicine and Pharmacy
Conditions: Cardiovascular-Kidney-Metabolic Syndrome; Atrial Cardiomyopathy; Atrial Fibrillation; Chronic Kidney Disease; Metabolic Syndrome
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Prevalence of atrial cardiomyopathy (ACM) across CKM syndrome stages [Baseline (single evaluation visit)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.